Abstract
Adherence to asthma medications presents a problem in all age groups, and older people with chronic illnesses such as asthma also have multiple co-morbidities and consequently complex healthcare needs. It has been suggested that older people are also less likely to adhere to medication and treatment than younger people. Although the prevalence of asthma in older people is similar to that of the general population, over two-thirds of those who die from asthma are >50 years of age and there is strong evidence for under-diagnosis. Clinicians therefore face specific challenges in providing healthcare with respect to both asthma diagnosis and treatment in older age groups. Non-adherence to medication can be defined as either ‘intentional’ or ‘unintentional’. Unintentional non-adherence is more likely to be associated with sociodemographic or physical barriers to the use of medication. Intentional non-adherence results from the balance of individual reasoning of risks versus the benefits of taking medication and acceptance of asthma diagnosis. Intentional non-adherence can be addressed through strategies that influence health beliefs and concerns about the adverse effects of medicine. Unintentional adherence can be addressed by assessing and educating the patient in relation to device use and providing education and clear written instructions about medication requirements. However, some barriers to medication use, such as financial ones, may be systematic. Most studies of medication use, efficacy, adverse effects and adherence in patients with asthma primarily involve younger people. Studies of strategies to improve asthma adherence outcomes specifically in older people are urgently needed.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Global Initiative for Asthma (GINA). Asthma management and prevention: a practical guide for public health officials and health care professionals. London: Imperial College, GINA, 2001
Australian Centre for Asthma Monitoring. Asthma in Australia 2005. AIHW Asthma Series 2. AIHW cat. no. ACM 6. Canberra (ACT): AIHW, 2005
Campbell M, Cogman G, Holgate S, et al. Age specific trends in asthma mortality in England and Wales, 1983–95: results of an observational study. BMJ 1997; 314: 1439–41
Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma-United States, 1980–1999. MMWR Surveill Summ 2002 Mar 29; 51(1): 1–13
Enright P, Kronmal R, Higgins M, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994; 106: 827–34
Kitch B, Levy B, Fanta C. Late onset asthma: epidemiology, diagnosis and treatment. Drugs Aging 2000; 17: 385–97
Wilson D, Appleton S, Adams R, et al. Undiagnosed asthma in older people: an underestimated problem. Med J Aust 2005; 183(1 Suppl.): S20–2
Krishnan V, Diette G, Rand C, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006; 174: 633–8
Guidelines for the diagnosis and management of asthma. Expert Panel Report II. NIH publication no. 97-4501. Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute, 1997
Enright P. The diagnosis and management of asthma is much tougher in older patients. Curr Opin Allergy Clin Immunol 2002; 2: 175–81
Braman S. Drug treatment of asthma in the elderly. Drugs 1996; 51: 415–22
Renwick D, Connolly M. Improving outcomes in elderly patients with asthma. Drugs Aging 1999; 14(1): 1–9
Masood D, Cheriyan S, Patterson R. Management of asthma in the geriatric population. Gerontology 1996; 42: 183–9
Weiss S, Petty T. Special challenges in managing asthma in the elderly: keys to unmasking a ‘hidden’ ailment. Consultant 1998; 38: 686–90
Barua P, O’Mahony M. Overcoming gaps in the management of asthma in older patients. Drugs Aging 2005; 22: 1029–59
Dow L. The diagnosis of asthma in older people. Clin Exp Allergy 1994; 24: 156–9
Enright PL, McClelland RL, Newman AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest 1999; 116: 603–13
Braman S. Asthma in the elderly. Clin Geriatr Med 2003; 19: 57–75
Walters K, Illiffe S, Orrell M. An exploration of help-seeking behaviour in older people with unmet needs. Fam Pract 2001; 18: 277–82
Moore ST. Marketing ambulatory services to the elderly. J Hosp Mark 1991; 6: 121–9
Abramson M. Respiratory symptoms and lung function in older people with asthma or chronic obstructive pulmonary disease. Med J Aust 2005; 183(1 Suppl.): S23–5
Dow L. Asthma in older people. Clin Exp Allergy 1998; 28: 195–202
Morris M. Difficulties with diagnosing asthma in the elderly. Chest 1999; 116: 591–3
Bashoura L, Hanania N. Cough may be the only presenting symptom: confronting the challenges of asthma in the elderly patient. J Respir Dis 2004; 25: 310–6
Asthma management handbook 2002. South Melbourne (VIC): National Asthma Council Australia (NACA), 2002
Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention: a pocket guide for physicians and nurses. Revised 2006 Dec. Bethesda (MD): Global Initiative for Asthma, National Heart, Lung, and Blood Institute, 2006 [online]. Available from URL: http://www.ginasthma.org/Guidelineitem.asp?ll=2&12=l&intld=37 [Accessed 2007 May 1]
Campbell DA, Luke CG, McLennan G, et al. Near-fatal asthma in South Australia: descriptive features and medication use. Aust N Z J Med 1996; 26(3): 356–62
Walters JA, Wood-Baker R, Walters EH. Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. Respir Med 2005; 99(4): 384–95
Salpeter S, Buckley N, Ormiston T, et al. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma related deaths. Ann Intern Med 2006; 144: 904–12
Beasley R, Pearce N, Crane J, et al. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999; 104 (2 Pt 2): S18–30
Newnham D. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Safety 2001; 24: 1065–80
Burgess C, D’Arcy C, Holman J. Adverse drug reactions in older Australians, 1981–2002. Med J Aust 2005; 182: 267–70
Clark N, Jones P, Keller S, et al. Patient factors and compliance with asthma therapy. Respir Med 1999; 93: 856–62
Gibson P, Powell H, Coughlan J, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002; (2): CD001005
Douglass J, Aroni R, Goeman D, et al. A qualitative study of action plans for asthma. BMJ 2002; 324: 1003–7
Jones A, Pill R, Adams S. Qualitative study of views of health professionals and patients on guided self-management plans for asthma. BMJ 2000; 321: 1507–10
Radecki S, Cowell W. Health promotion for elderly patients. Fam Med 1990; 22(4): 299–302
Abramson M, Bailey M, Couper F, et al. Are asthma medications and management related to deaths from asthma? Am J Resp Crit Care Med 2001; 163: 12–8
Ruffin R, Wilson D, Smith B, et al. Prevalence, morbidity and management of adult asthma in South Australia. Immunol Cell Biol 2001; 79: 191–4
Diette G, Krishnan J, Dominici F, et al. Asthma in older patients: factors associated with hospitalisation. Arch Intern Med 2002; 162: 1123–32
Adams R, Smith B, Ruffin R. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55: 566–73
Australian Bureau of Statistics (ABS) 2004–05 National Health Survey: Australian social trends 2006. ABS cat. no. 4102.0. Canberra (ACT): ABS, 2006
Australian Institute of health and Welfare (AIHW). Australia’s health 2002. AIHW cat. no. AUS25. Canberra (ACT): AIHW, 2002
Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the Asthma Policy Model. J Allergy Clin Immunol 2001; 108(1): 39–46
Schmier J, Halpern M, Jones M. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease. Drugs Aging 2005; 22: 717–29
Goeman D, Hogan C, Aroni R, et al. Barriers to delivering asthma care: a qualitative study of general practitioners. Med J Aust 2005; 183: 457–60
Douglass J, Goeman D, Yu E. Asthma 3+ Visit Plan: a qualitative evaluation. Intern Med J 2005; 35: 457–62
Armour C, Bosnic-Anticevich S, Saini B, et al. Pharmacists improving health care for asthma [abstract no. 120]. Proceedings of TSANZ 2006 Annual Scientific Meeting; 2006 Mar 24–29; Canberra (ACT)
Janson S, Hardie G, Fahy J, et al. Use of biological markers of airway inflammation to detect the efficacy of nurse-delivered asthma education. Heart Lung 2001; 30: 39–46
Centers for Disease Control and Prevention (CDC). Asthma mortality and hospitalization among children and young adults — United States, 1980–1993. MMWR Morb Mortal Wkly Rep 1996; 45: 350–3
Johnston S. Overview of virus-induced airway disease. Proc Am Thorac Soc 2005; 2: 150–6
Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999 Jan 30; 353(9150): 364–9
Robertson C, Rubinfeld A, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152: 511–7
Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004; 170: 1281–5
Biais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158(1): 126–32
Hartert T, Togias A, Meilen B, et al. Under utilisation of controller and rescue medication among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000; 48: 651–7
Apter A, Boston R, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it’s not just black and white. J Allergy Clin Immunol 2003; 111: 1219–26
Weinstein A. Should patients with persistent severe asthma be monitored for medication adherence? Ann Allergy Asthma Immunol 2005; 94: 251–7
van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 2003; 20: 229–40
Chapman KR, Walker L, Cluley S, et al. Improving patient compliance with asthma therapy. Respir Med 2000; 94: 2–9
Hippocrates. Decorum, c. 200BC. Quoted in: Sawyer S. Adherence: whose responsibility? In: A decade of coordinated asthma management in Australia. Melbourne (VIC): National Asthma Campaign, 1998: 9–10
Cockburn J. Patient education and strategies to improve adherence. In: Wall R, Jenkins C, editors. Understanding asthma. Sydney (NSW): Maclennan & Petty, 2000
MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231–55
National Asthma Campaign Ltd (NAC). Asthma adherence: a guide for health professionals. South Melbourne (VIC): NAC Ltd, 1999
Haynes RB, McDonald H, Garg AX, et al. Interventions for helping patients to follow prescriptions for medications. Coch-rane Database Syst Rev 2002; (2): CD000011
Spector S. Noncompliance with asthma therapy: are there solutions? J Asthma 2000; 37: 381–8
Ferner RE. Is concordance the primrose path to health? BMJ 2003; 327: 821–2
Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 44: 224–9
Delado P. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry 2000; 61: 6–9
Allen S. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 1997; 26: 83–6
Basheti I, Reddel H, Armour C, et al. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005; 50: 617–23
Allen S, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 1986; 80: 45–9
Allen S, Harries D. Which inhaler for the elderly asthmatic? Geriatr Med 1989; 19: 61–3
Irwin R, Richardson ND. Side effects with inhaled corticosteroids: the physician’s perception. Chest 2006; 130 (1 Suppl.): S41–53
Ullah M, Newman G. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981; 36: 523–9
Piette J, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med 2005; 165: 1749–55
Goeman D, Aroni R, Stewart K, et al. Patients’ views of the burden of asthma: a qualitative study. Med J Aust 2002; 177: 295–9
Adams S, Pill R, Jones A, et al. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med 1997; 45: 189–201
Conrad P. The meaning of medications: another look at compliance. Soc Sci Med 1985; 20: 29–37
Britten N. Does a prescribed treatment match a patient’s priorities? BMJ 2003; 327: 840
Byer B, Myers L. Psychological correlates of adherence to medication in asthma. Psychol Health Med 2000; 5: 389–93
Wroe AL. Intentional and unintentional non-adherence: a study of decision making. J Behav Med 2002; 25(4): 355–72
Bender BG. Overcoming barriers to non-adherence in asthma treatment. J Allergy Clin Immunol 2002; 109 (6 Suppl.): S554–9
Sin D, Tu J. Under use of inhaled steroid therapy in elderly patients with asthma. Chest 2001; 119: 720–5
Barr G, Somers S, Speizer F, et al. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002; 162: 1761–8
Osman LM. How do patients’ views about medication affect their self-management in asthma? Patient Educ Couns 1997; 32 (1 Suppl.): S43–9
Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130 (1 Suppl.): 65S–72S
Donovan J, Blake D. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992; 34: 507–13
van Schayck CP, Bijl-Hofland ID, Folgering H, et al. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002; 20: 126–8
Pedersen S. Inhalers and nebulisers: which to choose and why. Respir Med 1996; 90: 69–77
Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med 2002; 78: 37–9
Stevens D, Sharma L, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma 2003; 40: 789–93
Home R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1998; 14: 1–24
Jessop D, Rutter D. Adherence to asthma medications: the role of illness representations. Psychol Health 2003; 18: 595–612
Home R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555–67
Home R, Weinman J. Self-regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non adherence to preventer medication. Psychol Health 2002; 17: 17–32
Jones GK, Bell J, Fehrenbach C, et al. Understanding patient perceptions of asthma: results of the Asthma Control and Expectations (ACE) survey. Int J Clin Pract 2002; 56: 89–93
Jenkins L, Britten N, Stevenson F, et al. Developing and using quantitative instruments for measuring doctor-patient communication about drugs. Patient Educ Couns 2003; 50: 273–8
Hand CH, Bradley C. Health beliefs of adults with asthma: toward an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996; 33: 331–8
Irwin R, Richardson N. Patient focused care: using the right tools. Chest 2006; 130: 73S–82S
Luskin AT. Relationship: the forgotten component. Ann Allergy Asthma Immunol 1998; 81: 519–21
Onyirimba F, Apter AJ, Reisine S, et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol 2003; 90: 411–5
Fish L, Lung CL. Adherence to asthma therapy. Ann Allergy Asthma Immunol 2001; 86: 24–30
Shiffman R, Freudigman M, Brandt C, et al. A guideline implementation system using handheld computers for office management of asthma: effects on adherence and patient outcomes. Pediatrics 2000; 105: 767–73
Levy ML. Organized care in general practice: structure and evaluation. Respir Med 1997; 91: 578–80
Kolbe J. Asthma education, action plans, psychosocial issues and adherence. Can Respir J 1999; 6: 273–80
Tomlins R, Hope K. Proactive asthma care: the benefits of behavioural change. Aust Fam Physician 2001 Feb; 30(2): 127
Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid life: a qualitative study of attitudes to drug use. BMJ 2003; 327: 837–40
George M, Freedman T, Norfleet A, et al. Qualitative research-enhanced understanding of patients’ beliefs: results of focus groups with low income, urban, African American adults with asthma. J Allergy Clin Immunol 2003; 111: 967–73
Schmaling KB, Afari N, Blume A, et al. Assessment of psychological factors associated with adherence to medication regimens among adult patients with asthma. J Asthma 2000; 37: 335–43
Campbell D, Yellowlees P, McLennan G, et al. Psychiatric and medical features of near fatal asthma. Thorax 1995; 50: 254–9
Harrison B. Psychosocial aspects of asthma in adults. Thorax 1998; 53: 519–25
Harrison B. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005; 35: 543–7
Bender B, Milgrom H, Apter A, et al. Adherence intervention research: what have we learned and what do we do next? J Allergy Clin Immunol 2003; 112: 489–94
Elwyn G, Edwards A, Britten N, et al. Doing prescribing: how doctors can be more effective. BMJ 2003; 327: 846–7
Stevenson F, Gerrett D, Rivers P, et al. GPs’ recognition of and response to influences on patients’ medicine taking: the implications for communication. Fam Pract 2000; 17: 119–23
Bissell P, May C, Noyce P, et al. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med 2004; 58: 851–62
Stevenson F, Scambler G. The relationship between medicine and the public: the challenge of concordance. Health 2005; 9: 5–21
Ryan-Woolley BM, Rees JA. Initializing concordance in frail elderly patients via a medicines organizer. Ann Pharmacother 2005; 39: 834–9
Jones G. Prescribing and taking medicines. BMJ 2003; 327: 819
Benson J, Britten N. What effects do patients feel from their ICS medication and how do they react? Fam Pract 2006; 23: 80–7
Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005; 61: 133–55
Acknowledgements
No sources of funding were used to assist in the preparation of this review. Dr Douglass has received travel sponsorship from AstraZeneca, GlaxoSmithKline and Altana Pharma to attend international conferences. The authors have no other potential conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goeman, D.P., Douglass, J.A. Optimal Management of Asthma in Elderly Patients. Drugs Aging 24, 381–394 (2007). https://doi.org/10.2165/00002512-200724050-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200724050-00003